+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Respiratory Durable Medical Equipment Market Size, Share & Trends Analysis Report by Product Offering, Distribution & Service Channel, Notable States, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 330 Pages
  • January 2026
  • Region: United States
  • Grand View Research
  • ID: 6228000
REQUEST CUSTOMIZATION
Description Jump to:
The U.S. respiratory durable medical equipment (DME) market size was valued at USD 4.01 billion in 2025 and is projected to reach USD 5.89 billion by 2033, growing at a CAGR of 4.93% from 2026 to 2033. This growth is attributed to the technological advances smaller, more efficient portable oxygen concentrators, improved non-invasive home ventilators and connected PAP machines.

In addition, higher chronic respiratory disease prevalence (notably COPD and related comorbidities) in many Midwestern states together with an older, Medicare-heavy population and large rural patient cohorts who prefer home-based care, creates enduring demand for concentrators, portable oxygen systems and home ventilators. The Midwest has a comparatively higher prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing, largely due to an aging population and higher smoking prevalence in certain states.

According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States are living with COPD, which remains a leading cause of morbidity and mortality and is associated with an estimated USD 50 billion in annual healthcare costs. The increasing burden of COPD, combined with the need for non-invasive ventilation to manage hypercapnia, acute exacerbations, and sleep-disordered breathing in these patients, has fueled demand for home and hospital-based BiPAP/VPAP devices.

States such as Ohio, Michigan, Indiana, Illinois, and Missouri report a significant burden of COPD and obstructive sleep apnea (OSA), directly supporting demand for oxygen concentrators, CPAP/BiPAP devices, nebulizers, and ventilatory support equipment. The region’s aging demographic profile further accelerates adoption, as older adults are more likely to require long-term respiratory support and post-acute care equipment following hospital discharge.

Moreover, the strong emphasis on home-based care and cost containment across Midwestern healthcare systems, hospitals, and payers is actively shifting respiratory care from inpatient to home settings to reduce length of stay and readmission penalties, increasing reliance on DME providers for long-term oxygen therapy, sleep therapy devices, and remote patient monitoring-enabled respiratory equipment. This trend is fueled by Medicare and Medicaid reimbursement structures, which incentivize home oxygen and sleep therapy utilization, particularly in rural and semi-urban areas that characterize much of the Midwest. In addition, the Midwest has a relatively high proportion of Medicare beneficiaries, making federal reimbursement policies a critical demand driver for respiratory DME volumes.

For instance, Nebraska’s payer pattern reflects a mixed urban-rural respiratory profile, where PAP devices tilt toward Medicaid because sleep apnea incidence is higher in the adult, non-elderly population than in the 65+ group. Medicare still contributes substantially but remains secondary as its coverage primarily captures older COPD-dominant cohorts. However, oxygen concentrators, ventilators, and nebulizers lean strongly toward Medicare, consistent with Nebraska’s aging COPD and chronic respiratory population that relies more on federal senior coverage. Private plans track smaller shares due to lower employer-sponsored penetration in rural counties.

U.S. Respiratory Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. respiratory durable medical equipment (DME) market report based on product offerings, distribution & service channel, and Midwest states:

Product Offerings Outlook (Revenue, USD Million, 2021-2033)

  • Sleep Apnea Devices
  • Oxygen Therapy
  • Nebulizer Equipment
  • Home & Transport Ventilators
  • Masks, Tubing, Filters & Resupply Items (Consumables)

Distribution & Service Channel Outlook (Revenue, USD Million, 2021-2033)

  • National DME Networks
  • Regional Independents
  • Hospital/IDN Homecare Extensions
  • Online DME Retailers

Notable States (Midwest Only) Outlook (Revenue, USD Million, 2021-2033)

  • Nebraska (NE)
  • Iowa (IA)
  • Kansas (KS)
  • South Dakota (SD)
  • North Dakota (ND)
  • Missouri (MO)
  • Minnesota (MN)
  • Wisconsin (WI)
  • Illinois (IL)
  • Colorado (CO)
  • Wyoming (WY)
  • Ohio (OH)
  • Indiana (IN)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Objectives
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 List of Secondary Sources
1.4 List of Abbreviation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product and End Use Outlook
2.3 Competitive Landscape
Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis
3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
3.3.1 Sleep Apnea Devices
3.3.1.1 Sleep Apnea Devices Market, 2021-2033 (USD Million)
3.3.1.2 Auto-titrating CPAP
3.3.1.3 Fixed CPAP
3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
3.3.1.5 Integrated Humidifiers
3.3.2 Oxygen Therapy
3.3.2.1 Oxygen Therapy Market, 2021-2033 (USD Million)
3.3.2.2 Stationary Oxygen Concentrators
3.3.2.3 Portable Oxygen Concentrators (POCs)
3.3.2.4 Cylinders & regulators
3.3.2.5 Conservers
3.3.3 Nebulizer Therapy Equipment
3.3.3.1 Nebulizer Therapy Equipment Market, 2021-2033 (USD Million)
3.3.3.2 Compressor nebulizers
3.3.3.3 Mesh Nebulizers
3.3.3.4 Drug-specific Nebulizers
3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021-2033 (USD Million)
3.3.4.2 CPAP Masks & Cushions
3.3.4.3 Oxygen tubing & filters
3.3.4.4 Humidifier Chambers
3.3.4.5 Bacterial/Viral (B/V)
3.3.4.6 Aerosol Delivery Accessories
3.3.5 Home & Transport Ventilators
3.3.5.1 Home & Transport Ventilatorsmarket, 2021-2033 (USD Million)
3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
3.3.5.3 Portable Ventilators (Transport/ALS)
Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis
4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
4.3.1 National Dme Networks
4.3.1.1 National DME Networks market, 2021-2033 (USD Million)
4.3.2 Regional Independents
4.3.2.1 Regional Independents Market, 2021-2033 (USD Million)
4.3.3 Hospital/Idn Homecare Extensions
4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021-2033 (USD Million)
4.3.4 Online Dme Retailers
4.3.4.1 Online DME Retailers Market, 2021-2033 (USD Million)
Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021-2033, (Revenue, USD Million)
5.1 Midwest
5.1.1 Nebraska
5.1.1.1 Nebraska Respiratory DME Market, 2021-2033 (USD Million)
5.1.1.2 Demand & Patient Population
5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.1.3 Supplier Density & Network Mapping
5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
5.1.1.5.1 Sleep Clinics
5.1.1.5.2 Pulmonologists
5.1.1.5.3 Hospitals
5.1.1.5.4 Other providers
5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
5.1.1.7 Research Methodology
5.1.2 IOWA
5.1.2.1 Iowa Respiratory DME Market, 2021-2033 (USD Million)
5.1.2.2 Demand & Patient Population
5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
5.1.2.3 Supplier Density & Network Mapping
5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
5.1.2.5.1 Sleep Clinics
5.1.2.5.2 Pulmonologists
5.1.2.5.3 Hospitals
5.1.2.5.4 Other providers
5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
5.1.2.1 Research Methodology
5.1.3 KANSAS
5.1.3.1 Kansas Respiratory DME Market, 2021-2033 (USD Million)
5.1.3.2 Demand & Patient Population
5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.3.3 Supplier Density & Network Mapping
5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
5.1.3.5.1 Sleep Clinics
5.1.3.5.2 Pulmonologists
5.1.3.5.3 Hospitals
5.1.3.5.4 Other providers
5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
5.1.3.7 Research Methodology
5.1.4 SOUTH DAKOTA
5.1.4.1 South Dakota Respiratory DME Market, 2021-2033 (USD Million)
5.1.4.2 Demand & Patient Population
5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.4.3 Supplier Density & Network Mapping
5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
5.1.4.5.1 Sleep Clinics
5.1.4.5.2 Pulmonologists
5.1.4.5.3 Hospitals
5.1.4.5.4 Other providers
5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
5.1.4.7 Research Methodology
5.1.5 North Dakota
5.1.5.1 North Dakota Respiratory DME Market, 2021-2033 (USD Million)
5.1.5.2 Demand & Patient Population
5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.5.3 Supplier Density & Network Mapping
5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
5.1.5.5.1 Sleep Clinics
5.1.5.5.2 Pulmonologists
5.1.5.5.3 Hospitals
5.1.5.5.4 Other providers
5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
5.1.5.7 Research Methodology
5.1.6 Missouri
5.1.6.1 Missouri Respiratory DME Market, 2021-2033 (USD Million)
5.1.6.2 Demand & Patient Population
5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.6.3 Supplier Density & Network Mapping
5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
5.1.6.5.1 Sleep Clinics
5.1.6.5.2 Pulmonologists
5.1.6.5.3 Hospitals
5.1.6.5.4 Other providers
5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
5.1.6.7 Research Methodology
5.1.7 Minnesota
5.1.7.1 Minnesota Respiratory DME Market, 2021-2033 (USD Million)
5.1.7.2 Demand & Patient Population
5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.7.3 Supplier Density & Network Mapping
5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
5.1.7.5.1 Sleep Clinics
5.1.7.5.2 Pulmonologists
5.1.7.5.3 Hospitals
5.1.7.5.4 Other providers
5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
5.1.7.7 Research Methodology
5.1.8 Wisconsin
5.1.8.1 Wisconsin Respiratory DME Market, 2021-2033 (USD Million)
5.1.8.2 Demand & Patient Population
5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.8.3 Supplier Density & Network Mapping
5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
5.1.8.5.1 Sleep Clinics
5.1.8.5.2 Pulmonologists
5.1.8.5.3 Hospitals
5.1.8.5.4 Other providers (PCP, ENT, etc.)
5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
5.1.8.7 Research Methodology
5.1.9 Illinois
5.1.9.1 Illinois Respiratory DME Market, 2021-2033 (USD Million)
5.1.9.2 Demand & Patient Population
5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.9.3 Supplier Density & Network Mapping
5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
5.1.9.5.1 Sleep Clinics
5.1.9.5.2 Pulmonologists
5.1.9.5.3 Hospitals
5.1.9.5.4 Other providers (PCP, ENT, etc.)
5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
5.1.9.7 Research Methodology
5.1.10 Colorado
5.1.10.1 Colorado Respiratory DME Market, 2021-2033 (USD Million)
5.1.10.2 Demand & Patient Population
5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.10.3 Supplier Density & Network Mapping
5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
5.1.10.5.1 Sleep Clinics
5.1.10.5.2 Pulmonologists
5.1.10.5.3 Hospitals
5.1.10.5.4 Other providers (PCP, ENT, etc.)
5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
5.1.10.7 Research Methodology
5.1.11 WYOMING
5.1.11.1 Wyoming Respiratory DME Market, 2021-2033 (USD Million)
5.1.11.2 Demand & Patient Population
5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.11.3 Supplier Density & Network Mapping
5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
5.1.11.5.1 Sleep Clinics
5.1.11.5.2 Pulmonologists
5.1.11.5.3 Hospitals
5.1.11.5.4 Other providers (PCP, ENT, etc.)
5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
5.1.11.7 Research Methodology
5.1.12 OHIO
5.1.12.1 Ohio Respiratory DME Market, 2021-2033 (USD Million)
5.1.12.2 Demand & Patient Population
5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.12.3 Supplier Density & Network Mapping
5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
5.1.12.5.1 Sleep Clinics
5.1.12.5.2 Pulmonologists
5.1.12.5.3 Hospitals
5.1.12.5.4 Other providers (PCP, ENT, etc.)
5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
5.1.12.7 Research Methodology
5.1.13 INDIANA
5.1.13.1 Indiana Respiratory DME Market, 2021-2033 (USD Million)
5.1.13.2 Demand & Patient Population
5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021-2033
5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
5.1.13.3 Supplier Density & Network Mapping
5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
5.1.13.5.1 Sleep Clinics
5.1.13.5.2 Pulmonologists
5.1.13.5.3 Hospitals
5.1.13.5.4 Other providers (PCP, ENT, etc.)
5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
5.1.13.7 Research Methodology
Chapter 6 Competitive Analysis
6.1 Participant’s Overview
6.1.1 Tier 1 (National DME Providers)
6.1.2 Tier 2 (OEM Manufacturers)
6.1.3 Tier 3 (Regional Independents)
6.2 Financial Performance
6.2.1 Tier 1 (National DME Providers)
6.2.1.1 Public Companies
6.2.1.2 Private Companies
6.2.2 Tier 2 (OEM Manufacturers)
6.2.2.1 Public Companies
6.2.2.2 Private Companies
6.2.3 Tier 3 (Regional Independents)
6.2.3.1 Private Companies
6.3 Product Benchmarking
6.3.1 Tier 1 (National DME Providers)
6.3.1.1 Sleep Apnea Devices
6.3.1.2 Oxygen Therapy
6.3.1.2.1 Portable Oxygen Concentrators
6.3.1.2.2 Stationary Oxygen Concentrators
6.3.1.3 Nebulizer Therapy Equipment
6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
6.3.1.5 Home & Transport Ventilators
6.3.2 Tier 2 (OEM Manufacturers)
6.3.2.1 Sleep Apnea Devices
6.3.2.2 Oxygen Therapy
6.3.2.2.1 Portable Oxygen Concentrators
6.3.2.2.2 Stationary Oxygen Concentrators
6.3.2.3 Nebulizer Therapy Equipment
6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
6.3.2.5 Home & Transport Ventilators
6.3.3 Tier 3 (Regional Independents)
6.3.3.1 Sleep Apnea Devices
6.3.3.2 Oxygen Therapy
6.3.3.2.1 Portable Oxygen Concentrators
6.3.3.2.2 Stationary Oxygen Concentrators
6.3.3.3 Nebulizer Therapy Equipment
6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
6.3.3.5 Home & Transport Ventilators
6.4 Participant Categorization
6.5 Company Market Position Analysis
6.5.1 Tier 1 (National DME Providers)
6.5.2 Tier 2 (OEM Manufacturers)
6.5.1 Tier 3 (Regional Independents)
6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s Exit Strategy Aims to Realign the Company with its Mission and Vision
6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s exit and its anticipated impact
6.6.2 Philips Respironics
6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
6.6.3 Fisher & Paykel Healthcare
6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
6.6.4 Invacare
6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
6.6.5 Resmed
6.6.5.1 ResMed’s Exit Strategy from the Portable Oxygen Concentrator (POC) Market
6.6.6 Medtronic
6.6.6.1 Medtronic Exit Strategy
6.6.7 Teleflex Incorporated
6.6.7.1 Teleflex Incorporated Exit Strategy
6.6.8 Breas Medical AB
6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
6.7 Strategy Mapping
6.7.1 Tier 1 (National DME Providers)
6.7.1.1 Mergers and Acquisitions
6.7.1.2 Collaborations & Partnerships
6.7.2 Tier 2 (OEM Manufacturers)
6.7.2.1 New Product Launch
6.7.2.2 Mergers and Acquisitions
6.7.2.3 Other Strategies
6.7.3 Tier 3 (Regional Independents)
6.7.3.1 Mergers and Acquisitions
6.8 List of Other Market Players
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 U.S. Respiratory Durable Medical Equipment Market, by Product Offering, 2021-2033 (USD Million)
Table 4 U.S. Respiratory Durable Medical Equipment market, by Distribution & Service Channels, 2021-2033 (USD Million)
Table 5 Reimbursement and Payer Landscape at Each Device Category for Nebraska
Table 6 Regulatory & Licensing Framework for Nebraska
Table 7 Reimbursement and Payer Landscape at Each Device Category for Iowa
Table 8 Regulatory & Licensing Framework for Iowa
Table 9 Reimbursement and Payer Landscape at Each Device Category for Kansas
Table 10 Regulatory & Licensing Framework for Kansas
Table 11 Reimbursement and Payer Landscape at Each Device Category for South Dakota
Table 12 Regulatory & Licensing Framework for South Dakota
Table 13 Reimbursement and Payer Landscape at Each Device Category for North Dakota
Table 14 Regulatory & Licensing Framework for North Dakota
Table 15 Reimbursement and Payer Landscape at Each Device Category for Missouri
Table 16 Regulatory & Licensing Framework for Missouri
Table 17 Reimbursement and Payer Landscape at Each Device Category for Minnesota
Table 18 Regulatory & Licensing Framework for Minnesota
Table 19 Reimbursement and Payer Landscape for Each Device Category for Wisconsin
Table 20 Regulatory & Licensing Framework for Wisconsin
Table 21 Reimbursement and Payer Landscape for Each Device Category for Illinois
Table 22 Regulatory & Licensing Framework for Illinois
Table 23 Reimbursement and Payer Landscape for Each Device Category for Colorado
Table 24 Regulatory & Licensing Framework for Colorado
Table 25 Reimbursement and Payer Landscape for Each Device Category for Wyoming
Table 26 Regulatory & Licensing Framework for Wyoming
Table 27 Reimbursement and Payer Landscape for Each Device Category for Ohio
Table 28 Regulatory & Licensing Framework for Ohio
Table 29 Reimbursement and Payer Landscape for Each Device Category for Indiana
Table 30 Regulatory & Licensing Framework for Indiana
List of Figures
Figure 1 U.S. Respiratory DME Market Segmentation
Figure 2 Market snapshot
Figure 3 Product and end use outlook (USD Million)
Figure 4 Competitive landscape
Figure 5 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
Figure 6 U.S. Respiratory Durable Medical Equipment Market by Product Offering :Market Share Analysis, 2025 & 2033
Figure 7 Sleep Apnea Devices Market, 2021-2033 (USD Million)
Figure 8 Oxygen Therapy Market, 2021-2033 (USD Million)
Figure 9 Nebulizer Therapy Equipment Market, 2021-2033 (USD Million)
Figure 10 Masks, Tubing, Filters & Resupply Items (Consumables) Market 2021-2033 (USD Million)
Figure 11 Home & Transport Ventilators Market 2021-2033 (USD Million)
Figure 12 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
Figure 13 U.S. Respiratory Durable Medical Equipment Market by Distribution & Service Channels : Market Share Analysis, 2025 & 2033
Figure 14 National DME Networks Market, 2021-2033 (USD Million)
Figure 15 Regional Independents Market 2021-2033 (USD Million)
Figure 16 Hospital/IDN Homecare Extensions Market 2021-2033 (USD Million)
Figure 17 Online DME Retailers Market 2021-2033 (USD Million)
Figure 18 Nebraska Respiratory DME Market, 2021-2033 (USD Million)
Figure 19 Iowa Respiratory DME Market, 2021-2033 (USD Million)
Figure 20 Kansas Respiratory DME Market, 2021-2033 (USD Million)
Figure 21 South Dakota Respiratory DME Market, 2021-2033 (USD Million)
Figure 22 North Dakota Respiratory DME Market, 2021-2033 (USD Million)
Figure 23 Missouri Respiratory DME Market, 2021-2033 (USD Million)
Figure 24 Minnesota Respiratory DME Market, 2021-2033 (USD Million)
Figure 25 Wisconsin Respiratory DME Market, 2021-2033 (USD Million)
Figure 26 Illinois Respiratory DME Market, 2021-2033 (USD Million)
Figure 27 Colorado Respiratory DME Market, 2021-2033 (USD Million)
Figure 28 Wyoming Respiratory DME Market, 2021-2033 (USD Million)
Figure 29 Ohio Respiratory DME Market, 2021-2033 (USD Million)
Figure 30 Indiana Respiratory DME Market, 2021-2033 (USD Million)
Figure 31 Company/Competition Categorization (Distributors)
Figure 32 Company/Competition Categorization (Manufacturers)
Figure 33 Company Market Position Analysis (Tier 1 (National DME Providers) )
Figure 34 Company Market Position Analysis (Tier 2 (OEM Manufacturers))
Figure 35 Company Market Position Analysis (Tier 3 Regional Independents)
Figure 36 Strategy Mapping (National DME Providers)
Figure 37 Strategy Mapping (OEM Manufacturers)
Figure 38 Strategy mapping (Regional Independents)

Companies Mentioned

The leading players profiled in this U.S. Respiratory Durable Medical Equipment market report include:
  • National DME Providers
  • Lincare Holdings Inc. (a subsidiary of Linde plc)
  • Apria Healthcare Group LLC (Owens & Minor)
  • AdaptHealth, LLC
  • Rotech Healthcare Inc.
  • OEM Manufacturers
  • ResMed
  • Koninklijke Philips N.V
  • Inogen
  • Drive Devilbiss International
  • Vyaire Medical
  • Breas Medical AB
  • Regional Independents
  • Home Oxygen Company
  • DME Supply USA
  • Kansas City Home Medical Supply
  • Integrated Respiratory Solutions

Table Information

Report AttributeDetails
No. of Pages330
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 4.01 Billion
Forecasted Market Value ( USD ) by 2033 $ 5.89 Billion
Compound Annual Growth Rate4.9%
Regions CoveredUnited States
No. of Companies Mentioned17

Related Topics

Related Reports

Sleep and Respiratory Care Market Outlook 2026-2031: Trends, Technology, and Competitive Landscape - Product Image

Sleep and Respiratory Care Market Outlook 2026-2031: Trends, Technology, and Competitive Landscape

  • Report
  • 138 Pages
  • Global
From
Sleep Apnea Device Market Summary: Trends, Technological Innovations, and Competitive Landscape 2026-2031 - Product Image

Sleep Apnea Device Market Summary: Trends, Technological Innovations, and Competitive Landscape 2026-2031

  • Report
  • 109 Pages
  • Global
From
Durable Medical Equipment (DME) Market Size, Share, Trends and Forecast by Product, End Use, and Region, 2025-2033 - Product Image

Durable Medical Equipment (DME) Market Size, Share, Trends and Forecast by Product, End Use, and Region, 2025-2033

  • Report
  • 135 Pages
  • Global
From
Digital Respiratory Devices Market - Global Forecast 2026-2032 - Product Image

Digital Respiratory Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Respiratory Assist Devices Market - Global Forecast 2026-2032 - Product Image

Respiratory Assist Devices Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.